Your browser doesn't support javascript.
loading
Genomics of lethal prostate cancer at diagnosis and castration resistance.
Mateo, Joaquin; Seed, George; Bertan, Claudia; Rescigno, Pasquale; Dolling, David; Figueiredo, Ines; Miranda, Susana; Nava Rodrigues, Daniel; Gurel, Bora; Clarke, Matthew; Atkin, Mark; Chandler, Rob; Messina, Carlo; Sumanasuriya, Semini; Bianchini, Diletta; Barrero, Maialen; Petermolo, Antonella; Zafeiriou, Zafeiris; Fontes, Mariane; Perez-Lopez, Raquel; Tunariu, Nina; Fulton, Ben; Jones, Robert; McGovern, Ursula; Ralph, Christy; Varughese, Mohini; Parikh, Omi; Jain, Suneil; Elliott, Tony; Sandhu, Shahneen; Porta, Nuria; Hall, Emma; Yuan, Wei; Carreira, Suzanne; de Bono, Johann S.
Afiliação
  • Mateo J; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.
  • Seed G; The Institute of Cancer Research, London, United Kingdom.
  • Bertan C; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Rescigno P; The Institute of Cancer Research, London, United Kingdom.
  • Dolling D; The Institute of Cancer Research, London, United Kingdom.
  • Figueiredo I; The Institute of Cancer Research, London, United Kingdom.
  • Miranda S; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Nava Rodrigues D; The Institute of Cancer Research, London, United Kingdom.
  • Gurel B; The Institute of Cancer Research, London, United Kingdom.
  • Clarke M; The Institute of Cancer Research, London, United Kingdom.
  • Atkin M; The Institute of Cancer Research, London, United Kingdom.
  • Chandler R; The Institute of Cancer Research, London, United Kingdom.
  • Messina C; The Institute of Cancer Research, London, United Kingdom.
  • Sumanasuriya S; The Institute of Cancer Research, London, United Kingdom.
  • Bianchini D; The Institute of Cancer Research, London, United Kingdom.
  • Barrero M; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Petermolo A; The Institute of Cancer Research, London, United Kingdom.
  • Zafeiriou Z; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Fontes M; The Institute of Cancer Research, London, United Kingdom.
  • Perez-Lopez R; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Tunariu N; The Institute of Cancer Research, London, United Kingdom.
  • Fulton B; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Jones R; The Institute of Cancer Research, London, United Kingdom.
  • McGovern U; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Ralph C; The Institute of Cancer Research, London, United Kingdom.
  • Varughese M; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Parikh O; The Institute of Cancer Research, London, United Kingdom.
  • Jain S; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Elliott T; The Institute of Cancer Research, London, United Kingdom.
  • Sandhu S; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • Porta N; Instituto Oncoclinicas-Grupo Oncoclinicas, Rio de Janeiro, Brazil.
  • Hall E; Vall d'Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, Spain.
  • Yuan W; The Institute of Cancer Research, London, United Kingdom.
  • Carreira S; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
  • de Bono JS; The Institute of Cancer Research, London, United Kingdom.
J Clin Invest ; 130(4): 1743-1751, 2020 04 01.
Article em En | MEDLINE | ID: mdl-31874108

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Perfilação da Expressão Gênica / Genômica / Neoplasias de Próstata Resistentes à Castração / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Perfilação da Expressão Gênica / Genômica / Neoplasias de Próstata Resistentes à Castração / Proteínas de Neoplasias Tipo de estudo: Clinical_trials / Diagnostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article